Rodi Pharma Inc is categorized under Research and Development Laboratories in Del Mar, CA and active since 2002.
Rodi Pharma Inc was established in 2002, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Research and Development Laboratories business, which does work in the B2B market, and is classified as a Research and Development Laboratories, under code number 6213400 by the NAICS.
If you are seeking more information, feel free to contact Charles Rodi, President at the company’s single location by writing to 13823 Recuerdo Drive, Del Mar, California CA 92014 or by phoning (858) 353-1084. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Rodi Pharma Inc |
| Contact Person: | Charles Rodi, President |
| Address: | 13823 Recuerdo Drive, Del Mar, California 92014 |
| Phone Number: | (858) 353-1084 |
| Annual Revenue (USD): | $100.000 to $499.999 |
| Founded: | 2002 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Research and Development Laboratories |
| SIC Code: | 8731 |
| NAICS Code: | 6213400 |
| Share This Business: |
Rodi Pharma Inc was started in 2002 to provide professional Research and Development Laboratories under the SIC code 8731 and NAICS code 6213400. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Charles Rodi, President for inquiries that concern Rodi Pharma Inc by calling the company number (858) 353-1084, as your correspondence is most welcome. Additionally, the physical location of the single location of Rodi Pharma Inc can be found at the coordinates 32.949193,-117.25212 as well as the street address 13823 Recuerdo Drive in Del Mar, California 92014.
For its online presence, you may visit Rodi Pharma Inc’s website at and engage with its social media outlets through on Twitter and on Facebook.